|
| 36754704 | Early-onset parkinsonism and hereditary spastic paraplegia type 7: pearls and pitfalls. | Parkinsonism Relat Disord | 2023 |
| 37670776 | The Parkinson's disease waiting room of the future: measurements, not magazines. | Front Neurol | 2023 |
| 37563079 | Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort. | Parkinsonism Relat Disord | 2023 |
| 37578800 | IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial. | JAMA Neurol | 2023 |
| 37495500 | Establishing a framework for quality of inpatient care for Parkinson's disease: A study on inpatient medication administration. | Parkinsonism Relat Disord | 2023 |
| 37532622 | Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial. | Parkinsonism Relat Disord | 2023 |
| 37448833 | Adopting a palliative care mindset is an unmet need in Parkinson's disease. | Clin Park Relat Disord | 2023 |
| 36566709 | Goodbyes, thank you, and cutting cake⿦. | Parkinsonism Relat Disord | 2023 |
| 34117537 | Correction to: Genetic updates on paroxysmal dyskinesias. | J Neural Transm (Vienna) | 2022 |
| 35732087 | Thrombolysis Experience in Costa Rica Compared Against Individual Patient Data from two Randomized Controlled Trials. | J Stroke Cerebrovasc Dis | 2022 |
| 35461777 | Looking back the importance of genetics in a patient with Parkinson disease and deep brain stimulation. | Parkinsonism Relat Disord | 2022 |
| 35662127 | A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies. | J Parkinsons Dis | 2022 |
| 36825053 | A Pilot Trial of Dopamine Replacement for Dynamic Facial Expressions in Parkinson's Disease. | Mov Disord Clin Pract | 2022 |
| 36182821 | Burning mouth syndrome to oral cenesthopathy: A spectrum of neuropsychiatric and sensory complications in neurodegenerative parkinsonism? | Parkinsonism Relat Disord | 2022 |
| 35909701 | Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review. | Clin Park Relat Disord | 2022 |
| 35921450 | Trial of Cinpanemab in Early Parkinson's Disease. | N Engl J Med | 2022 |
| 35280262 | Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study. | Front Neurol | 2022 |
| 32584654 | Implementation and Patient Experience of Outpatient Teleneurology. | Telemed J E Health | 2021 |
| 33715277 | Somatic symptoms have negligible impact on Patient Health Questionnaire-9 depression scale scores in neurological patients. | Eur J Neurol | 2021 |
| 33877451 | Dystonia and leveraging oral pharmacotherapy. | J Neural Transm (Vienna) | 2021 |
| 33868630 | Use of a Smartphone to Gather Parkinson's Disease Neurological Vital Signs during the COVID-19 Pandemic. | Parkinsons Dis | 2021 |
| 33868146 | ATP1A3-Related Disorders: An Ever-Expanding Clinical Spectrum. | Front Neurol | 2021 |
| 33590555 | Non-Motor Fluctuations in Parkinson's Disease: Validation of the Non-Motor Fluctuation Assessment Questionnaire. | Mov Disord | 2021 |
| 33929620 | Genetic updates on paroxysmal dyskinesias. | J Neural Transm (Vienna) | 2021 |
| 34887173 | Mind the gap: Inequalities in mental health care and lack of social support in Parkinson disease. | Parkinsonism Relat Disord | 2021 |
| 34695657 | Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications. | Parkinsonism Relat Disord | 2021 |
| 34486986 | Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson's Disease: A Pooled Analysis of 8 Phase 2b/3 Trials. | J Parkinsons Dis | 2021 |
| 34392372 | Estimating the Risk of Deep Brain Stimulation in the Modern Era: 2008 to 2020. | Oper Neurosurg (Hagerstown) | 2021 |
| 34276544 | Best Practices in the Clinical Management of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Consensus Statement of the CurePSP Centers of Care. | Front Neurol | 2021 |
| 33933853 | Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients. | Parkinsonism Relat Disord | 2021 |
| 34316669 | Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists. | Clin Park Relat Disord | 2021 |
| 34119931 | Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of view. | Parkinsonism Relat Disord | 2021 |
| 34307747 | An Open-Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia. | Mov Disord Clin Pract | 2021 |
| 33454196 | When patients lead: An editorial to 'self-concocted, curious, and creative coping strategies in movement disorders' by Mulroy et al. | Parkinsonism Relat Disord | 2021 |
| 33394100 | High intensity aerobic exercise improves information processing and motor performance in individuals with Parkinson's disease. | Exp Brain Res | 2021 |
| 31432068 | Factors Associated With Postoperative Confusion and Prolonged Hospital Stay Following Deep Brain Stimulation Surgery for Parkinson Disease. | Neurosurgery | 2020 |
| 31892635 | Palatal myoclonus, abnormal eye movements, and olivary hypertrophy in GAD65-related disorder. | Neurology | 2020 |
| 31882528 | Unique white matter structural connectivity in early-stage drug-naive Parkinson disease. | Neurology | 2020 |
| 32033988 | Child Neurology: Genetically determined dystonias with childhood onset. | Neurology | 2020 |
| 33046383 | Untangling the complicated web of ATP1A3 mutations. | Parkinsonism Relat Disord | 2020 |
| 32712560 | Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosis. | Parkinsonism Relat Disord | 2020 |
| 32935299 | Pharmacological Treatment of Early Motor Manifestations of Parkinson Disease (PD). | Neurotherapeutics | 2020 |
| 32881874 | Correlation between brain volume and retinal photoreceptor outer segment volume in normal aging and neurodegenerative diseases. | PLoS One | 2020 |
| 32146504 | Botulinum neurotoxin injections for muscle-based (dystonia and spasticity) and non-muscle-based (neuropathic pain) pain disorders: a meta-analytic study. | J Neural Transm (Vienna) | 2020 |
| 32146380 | Delivering patient-centered care in Parkinson's disease: Challenges and consensus from an international panel. | Parkinsonism Relat Disord | 2020 |
| 32513552 | Adaptive neurology in COVID-19 times. | Parkinsonism Relat Disord | 2020 |
| 30502095 | Exploring bedside clinical features of parkinsonism: A focus on differential diagnosis. | Parkinsonism Relat Disord | 2019 |
| 31296586 | Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia. | J Neurol Neurosurg Psychiatry | 2019 |
| 31420757 | Tardive Dyskinesia: Treatment Update. | Curr Neurol Neurosci Rep | 2019 |
| 31304406 | Height and weight changes after deep brain stimulation in patients with Parkinson disease: role of clinical subtypes. | Heliyon | 2019 |